Sun Pharma launches Tedizolid Phosphate tablets 200 mg in India
Sun Pharmaceutical Industries has launched Tedizolid Phosphate tablets 200 mg in India under the brand name STARIZO. STARIZO (Tedizolid Phosphate) is a novel, oxazolidinone-class antibacterial, used to treat Acute Bacterial Skin and Skin Structure Infection (ABSSSI).
Sun Pharma has obtained rights from Merck Sharp & Dohme Singapore Trading to develop, manufacture and commercialise Tedizolid Phosphate in India.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Aug 23 2024 | 2:54 PM IST